Doximity signals FY2027 revenue of $671M-$681M while expanding AI investment with 165 signed health system AI clients
Doximity, based on expanded AI investment and securing 165 subscribed health system AI clients, forecasts FY2027 revenue of $671 million to $681 million.
The current price of $20.66 is above the support level of $19.88, allowing us to rely on downside rigidity, but we will consider entry cautiously, keeping in mind that a rebound may be limited amid misaligned moving averages and a downtrend.
After entering at the current price of $20.66, I will take profit if the resistance level of $22.79 is reached, and I will cut losses if the support level of $19.88 is broken and the downtrend continues.
The 14‑day RSI is 42.4, indicating a neutral level, while the moving averages are in a disordered arrangement. Trading volume surged to 7.56 times the 20‑day average, and the price change over the past seven days was –3.6%.
Initially, we projected a limited rebound between the support level of $19.88 and the resistance level of $22.79, targeting a conservative return of 2.0%. However, the actual outcome was a massive surge of 42.4%, resulting in an OVERHIT rating. Despite an enormous volume spike of 7.56 times the 20‑day average at entry, we were constrained by technical limitations—namely, a misaligned moving average and a downtrend—and thus could not fully trust the explosive buying pressure in advance, which is regrettable.
Through this trading, when volume surges to several times the normal level accompanied by major positive news, we will cultivate flexibility to avoid setting target prices too conservatively by being bound only to abnormal technical indicator readings or a downtrend. In future similar volume‑surge situations, we will keep the sustainability of momentum open and adjust our response strategy.